838
Vol. 58, No. 6
158.02 (C-5). MS (EI) m/z: 386 [M]ꢄ. Anal. Calcd for C18H18N4O6: C,
55.95; H, 4.66; N, 14.50. Found: C, 55.99; H, 4.62; N, 14.52%.
2-[(Z)-3-(2,4-Dichlorophenyl)-1-[(Z)-2-(2,4-dichlorophenyl)-1-(3-
methyl-4-nitro-5-isoxazolyl)-1-ethenyl]-2-(3-methyl-4-nitro-5-isoxazolyl)-
2-propenyl]phenol (Entry 4, Table 4) IR ( KBr): 980 (CꢁC),1575
(ꢁNꢄ–Oꢀ), 1630 (CꢁN), cmꢀ1; 1H-NMR (300 MHz, CDCl3) d: 2.2 (s, 6H,
2CH3), 4.3 (s, 1H, benzylic H), 6.2 (s, 2H, 2ꢁCH), 6.8—7.5 (m, 10H, ArH),
9.5 (br s, 1H, OH, D2O exchangeable). MS (EI) m/z: 700 [M]ꢄ. Anal. Calcd
for C31H20N4O7Cl4: C, 53.14; H, 2.85; N, 8.00. Found: C, 53.10; H, 2.88; N,
8.05%.
5-[(Z)-4-(4-Chlorophenyl)-1-[(Z)-1-(4-chlorophenyl)methylidene]-3-(3-
methyl-4-nitro-5-isoxazolyl)-2-(4-methylphenyl)3-butenyl]-3methyl-4-
nitro-isoxazole (Entry 5, Table 4) IR (KBr): 975 (CꢁC), 1560 (ꢁNꢄ–
Oꢀ), 1615 (CꢁN), cmꢀ1; 1H-NMR (300 MHz, CDCl3) d: 2.3 (s, 6H, 2CH3),
2.5 (s, 3H, CH3), 4.1 (s, 1H, benzylic H), 6.2 (s, 2H, 2CH), 6.9—7.6 (m,
12H, ArH). MS (EI) m/z: 630 [M]. Anal. Calcd for C32H24N4O6Cl2: C,
60.95; H, 3.80; N, 8.88. Found: C, 60.99; H, 3.81; N, 8.85%.
2-Methoxy-4-{2-(3-methyl-4-nitro-5-isoxazolyl)-1-[(3-methyl-4-nitro-
5-isoxazolyl)methyl]ethyl}phenol (Entry 3, Table 3) White solid; IR
1
(KBr): 1572 (ꢁNꢄ–Oꢀ), 1620 (CꢁN), cmꢀ1; H-NMR (300 MHz, CDCl3)
d: 2.3 (s, 6H, 2CH3), 3.5 (dd, 2H, Jꢁ14, 8 Hz, CH2CH), 3.7 (dd, 2H, Jꢁ14,
8 Hz, CH2CH), 3.9 (s, 3H, OCH3), 4.1 (quintet, 1H, Jꢁ8 Hz, CH Ar), 6.9—
7.5 (m, 3H, Ar-H), 8.5 (br s, 1H, D2O exchangeable) MS (EI) m/z: 418
[M]ꢄ. Anal. Calcd for C18H18N4O8: C, 51.67; H, 4.30; N, 13.39. Found: C,
51.71; H, 4.26; N, 13.43%.
N,N-Dimethyl-N-(4-{2-(3-methyl-4-nitro-5-isoxazolyl)-1-[(3-methyl-4-
nitro-5-isoxazolyl)methyl]ethyl}phenyl)amine (Entry 4, Table 3) White
solid; IR (KBr): 1575 (ꢁNꢄ–Oꢀ), 1615 (CꢁN), cmꢀ1; 1H-NMR (300 MHz,
CDCl3) d: 2.3 (s, 6H, 2CH3), 3.2 (s, 6H, 2NCH3), 3.6 (dd, 2H, Jꢁ14, 8 Hz,
CH2CH), 3.8 (dd, 2H, Jꢁ14, 8 Hz, CH2CH), 4.0 (quintet, 1H, Jꢁ8 Hz, CH
Ar), 6.8—7.4 (m, 4H, Ar-H). MS (EI) m/z: 415 [M]ꢄ. Anal. Calcd for
C19H21N5O6: C, 54.93; H, 5.06; N, 16.86. Found: C, 54.90; H, 5.01; N,
16.88%.
4-[(Z)-3-(2-(Chlorophenyl)-1-[(E)-2-(2-chlorophenyl)-1-(3-methyl-4-
nitro-5-isoxazolyl)-1-ethenyl]-2-(3-methyl-4-nitro-5-isoxazolyl)-2-
propenyl]-2-methoxyphenol (Entry 6, Table 4) IR (KBr): 975 (CꢁC),
1
1550 (ꢁNꢄ–Oꢀ), 1615 (CꢁN), cmꢀ1; H-NMR (300 MHz, CDCl3) d: 2.2
2-{2-(3-Methyl-4-nitro-5-isoxazolyl)-1-[(3-methyl-4-nitro-5-isoxa-
zolyl)methyl]ethyl}phenol (Entry 5, Table 3) White solid, mp; IR ( KBr):
(s, 6H, 2CH3), 3.8 (s, 3H, OCH3), 4.2 (s, 1H, benzylic H), 6.2 (s, 2H, 2ꢁ
CH), 6.8—7.5 (m, 11H, ArH), 9.0 (br s, 1H, OH, D2O exchangeable). MS
(EI) m/z: 662 [M]ꢄ. Anal. Calcd for C32H24N4O8Cl2: C, 58.00; H, 3.62; N,
8.45. Found: C, 58.04; H, 3.66; N, 8.41%.
1
1565 (ꢁNꢄ–Oꢀ), 1613 (CꢁN), cmꢀ1; H-NMR (300 MHz, CDCl3) d: 2.2
(s, 6H, 2CH3), 3.5 (dd, 2H, Jꢁ14, 8 Hz, CH2CH), 3.7 (dd, 2H, Jꢁ14, 8 Hz,
CH2CH), 4.0 (quintet, 1H, Jꢁ8 Hz, CH Ar), 7.0—7.5 (m, 4H, Ar-H), 9.5
(br s, 1H, OH, D2O exchangeable). MS (EI) m/z: 388 [M]ꢄ. Anal. Calcd for
C17H16N4O7: C, 52.57; H, 4.12; N, 14.43. Found: C, 52.61; H, 4.09; N,
14.45%.
N,N-Dimethyl-N-{4-[(Z)-2-(3-methyl-4-nitro-5-isoxazolyl)-1-[(Z)-1-(3-
methyl-4-nitro-5-isoxazolyl)-2-(2-methylphenyl)-1-ethenyl]-3-(2-
methylphenyl)-2-propenyl]phenyl}amine (Entry 7, Table 4) IR (KBr):
980 (CꢁC), 1575 (ꢁNꢄ–Oꢀ), 1630 (CꢁN), cmꢀ1 1H-NMR (300 MHz,
;
5-[2-(1,3-Benzodioxol-5-yl)-3-(3-methyl-4-nitro-5-isoxazolyl)propyl]-3-
methyl-4-nitroisoxazole (Entry 6, Table 3) White solid; IR (KBr): 1570
(ꢁNꢄ–Oꢀ), 1620 (CꢁN), cmꢀ1; 1H-NMR (300 MHz, CDCl3) d: 2.2 (s, 6H,
2CH3), 3.5 (dd, 2H, Jꢁ14, 8 Hz, CH2CH), 3.7 (dd, 2H, Jꢁ14, 8 Hz,
CH2CH), 4.1 (quintet, 1H, Jꢁ8 Hz, CH Ar), 5.0 (s, 2H, OCH2O), 6.9—7.3
(m, 3H, Ar-H). MS (EI) m/z: 416 [M]ꢄ. Anal. Calcd for C18H16N4O8: C,
51.92; H, 3.84; N, 13.46. Found: C, 51.90; H, 3.88; N, 13.50%.
CDCl3): d 2.3 (s, 6H, 2CH3), 2.5 (s, 6H, 2CH3), 3.2 (s, 6H, N(CH3)2), 4.0 (s,
1H, benzylic H), 6.2 (s, 2H, 2ꢁCH), 6.8—7.5 (m, 12H, ArH). MS (EI) m/z:
619 [M]ꢄ. Anal. Calcd for C35H33N5O6: C, 67.85; H, 5.33; N, 11.30. Found:
C, 67.88; H, 5.35; N, 11.27%.
5-{(Z)-2-(1,3-Benzodioxol-5-yl)-3(3-methyl-4-nitro-5-isoxazolyl)-4-
phenyl-1-[(Z)-1-phenylmethylidene]-3-butenyl}-3-methyl-4-nitro-isoxa-
zole (Entry 8, Table 4) IR (KBr): 970 (CꢁC), 1550 (ꢁNꢄ–Oꢀ), 1620
(CꢁN), cmꢀ1; 1H-NMR (300 MHz, CDCl3) d: 2.3 (s, 6H, 2CH3), 4.3 (s, 1H,
benzylic H), 5.0 (s, 2H, OCH2O), 6.1 (s, 2H, 2ꢁCH), 6.8—7.4 (m, 13H,
ArH). MS (EI) m/z: 592 [M]ꢄ. Anal. Calcd for C32H24N4O8: C, 64.86; H,
4.05; N, 9.45. Found: C, 64.85; H, 4.00; N, 9.40%.
General Procedure for Synthesis of 3-Methyl-5-{(Z)-3-(3-methyl-4-
nitro-5-isoxazolyl)-2,4-diphenyl-1-[(Z)-1-phenylmethylidene]-3-butenyl}-
4-nitroisoxazoles (6) in Ionic Liquid (Entry 1, Table 4) 3-Methyl-5-
[3-(3-methyl-4-nitro-5-isoxazolyl]-2-phenyl propyl]-4-nitroisoxazoles 7 (1
mmol) and aromatic aldehyde (2 mmol) were taken in IL, [bmIm]OH (5 ml)
and the reaction mixture was stirred at room temperature for 10—15 min.
The reaction was monitored by TLC. After the completion of the reaction,
the reaction mixture was extracted with ethyl acetate (3ꢃ10 ml). Evapora-
tion of ethyl acetate gave crude product, which was purified by recrystalliza-
tion from ethyl alcohol to give 6. The IL left over in the reaction was washed
with ethyl acetate and dried at 80 °C under vaccum and was further used for
conducting the reaction once again. It has been used for subsequent runs of
the reaction for five times. This procedure was followed for all the reactions
listed in Table 4. IR (KBr): 978 (CꢁC), 1550 (ꢁNꢄ–Oꢀ), 1630 (CꢁN),
General Procedure for Synthesis of 3-Methyl-6-[(3-methyl-5-phenyl-
4H-pyrrolo[2,3-d]isoxazol-6-yl)(phenyl)methyl]-5-phenyl-4H-
pyrrolo[2,3-d]isoxazoles (5) in Ionic Liquid (Entry 1, Table 5) A mix-
ture of benzyl bis-nitro styrylisoxazoles 6 (1 mmol) and SnCl2. 2H2O (5
mmol) were taken in IL [(HMIm)BF4] (5 ml), and the reaction mixture was
stirred at room temperature for 15—30 min. The termination of the reaction
was monitored by TLC. The product was extracted with ethyl acetate (2ꢃ
10 ml). Evaporation of ethyl acetate gave crude product, which was purified
by a short column chromatography over silica gel (benzene–ethyl acetate) to
provide the pure product, benzyl bis-pyrrolo[2,3-d]isoxazole as a pale yel-
low solid. The ionic liquid was dried under vacuum and reused for five reac-
tions by adding some more SnCl2·2H2O with out any loss of efficiency.
After five runs 50% of fresh IL and SnCl2·2H2O were added to it and this
was used again. This procedure was followed for all the reactions listed in
1
cmꢀ1; H-NMR (300 MHz, CDCl3) d: 2.3 (s, 6H, 2CH3), 4.2 (s, 1H, ben-
zylic H), 6.2 (s, 2H, 2ꢁCH), 6.9—7.5 (m, 15H, ArH). 13C-NMR (75 MHz)
d: 11.05 (C-6), 45.05 (C-9), 110.85 (C-4), 117.80 (C-7), 122.02 (C-8),
125.80 (Ar-C), 126.40 (Ar-C), 127.80 (Ar-C), 127.95 (Ar-C), 128.00 (Ar-
C), 128.70 (Ar-C), 129.10 (Ar-C), 129.22 (Ar-C), 130.00 (Ar-C), 131.07
(Ar-C), 137.06 (Ar-C), 137.50 (Ar-C), 155.45 (C-3), 158.90 (C-5). MS (EI)
m/z: 548 [M]ꢄ. Anal. Calcd for C31H24N4O6: C, 67.88; H, 4.37; N, 10.21.
Found: C, 67.85; H, 4.38; N, 10.20%.
Table 5. Pale color solid, IR (KBr): 3300 (S), 1600, 970 cmꢀ1 1H-NMR
;
(300 MHz, CDCl3) d: 2.3 (s, 6H, 2CH3), 4.6 (s, 1H, benzylic H), 7.2—7.8
(m, 15H, Ar-H), 8.1 (br s, 2H, pyrrole NH, D2O exchangeable). MS (EI)
m/z: 484 [M]ꢄ. 13C-NMR (75 MHz) d: 11.01 (C-7), 40.05 (C-8), 105.20 (C-
3ꢂ), 111.05 (C-6), 126.05 (Ar-C), 127.00 (Ar-C), 127.50 (Ar-C), 128.02 (Ar-
C), 128.75 (Ar-C), 128.99 (Ar-C), 130.02 (C-5), 131.75 (Ar-C), 133.50 (Ar-
C), 132.88 (Ar-C), 133.00 (Ar-C), 135.03 (Ar-C), 136.30 (Ar-C), 148.22 (C-
3), 155.40 (C-6ꢂ). Anal. Calcd for C31H24N4O2: C, 76.85; H, 4.95; N, 11.57.
Found: C, 76.88; H, 4.90; N, 11.58%.
3-Methyl-5-{(Z)-3-(3-methyl-4-nitro-5-isoxazolyl)-4-(4-
methylphenyl)1-[(Z)-1-(4-methylphenyl)methylidene]-2-phenyl-3-
butenyl}-4-nitroisoxazole (Entry 2, Table 4) IR (KBr): 980 (CꢁC),1570
1
(ꢁN–Oꢀ), 1625 (CꢁN), cmꢀ1; H-NMR (300 MHz, CDCl3) d: 2.3 (s, 6H,
2CH3), 2.5 (s, 6H, 2CH3), 4.2 (s, 1H, benzylic H), 6.1 (s, 2H, 2ꢁCH), 6.8—
7.4 (m, 13H, ArH). 13C-NMR (75 MHz) d: 11.40 (C-6), 21.75 (Ar-CH3),
45.13 (C-9), 111.25 (C-4), 118.50 (C-7), 125.05 (C-8), 126.05 (Ar-C),
126.80 (Ar-C), 127.95 (Ar-C), 128.03 (Ar-C), 128.75 (Ar-C), 129.00 (Ar-
C), 129.25 (Ar-C), 129.65 (Ar-C), 130.05 (Ar-C), 132.06 (Ar-C), 133.57
(Ar-C), 138.05 (Ar-C), 155.05 (C-3), 158.88 (C-5). MS (EI) m/z: 576 [M]ꢄ.
Anal. Calcd for C33H28N4O6: C, 68.75; H, 4.86; N, 9.72. Found: C, 68.77; H,
4.85; N, 9.70%.
3-Methyl-6-[(3-methyl-5-(4-methylphenyl)-4H-pyrrolo[2,3-d]isoxazol-
6-yl)(phenyl)methyl]-5-(4-methylphenyl)-4H-pyrrolo[2,3-d]isoxazole
(Entry 2, Table 5) Pale yellow solid, IR (KBr): 3250 (S), 1610, 980 cmꢀ1
;
1H-NMR (300 MHz, CDCl3) d: 2.2 (s, 6H, 2CH3), 2.5 (s, 6H, 2CH3), 4.8
(s, 1H, benzylic H), 6.8—7.6 (m, 13H, Ar-H), 8.5 (br s, 2H, pyrrole NH,
D2O exchangeable). 13C-NMR (75 MHz) d: 11.37 (C-7), 21.50 (Ar-CH3),
41.85 (C-8), 105.55 (C-3ꢂ), 111.85 (C-6), 125.85 (Ar-C), 126.85 (Ar-C),
127.05 (Ar-C), 127.95 (Ar-C), 128.33 (Ar-C), 128.87 (Ar-C), 130.08 (C-5),
131.21 (Ar-C), 131.95 (Ar-C), 132.05 (Ar-C), 133.08 (Ar-C), 135.00 (Ar-
C), 136.44 (Ar-C), 148.38 (C-3), 156.05 (C-6ꢂ). Anal. Calcd for
C31H24N4O2: C, 76.85; H, 4.95; N, 11.57. Found: C, 76.88; H, 4.90; N,
11.58%. MS (EI) m/z: 512 [M]ꢄ. Anal. Calcd for C33H28N4O2: C, 77.34; H,
5.46; N, 10.93. Found: C, 77.38; H, 5.40; N, 10.95%.
5-{(Z)-4-(4-Methoxyphenyl)1-[(Z)-1-(4-methoxyphenyl)methylidene]-
3-(3-methyl-4-nitro-5-isoxazolyl)-2-phenyl-3-butenyl}-4-nitroisoxazole
(Entry 3, Table 4) IR (KBr): 960 (CꢁC),1525 (ꢁNꢄ–Oꢀ), 1622 (CꢁN),
cmꢀ1 1H-NMR (300 MHz, CDCl3) d: 2.3 (s, 6H, 2CH3), 3.8 (s, 6H,
;
2OCH3), 4.1 (s, 1H, benzylic H), 6.2 (s, 2H, 2ꢁCH), 6.8—7.5 (m, 13H,
ArH). MS (EI) m/z: 608 [M]ꢄ. Anal. Calcd for C33H28N4O8: C, 65.13; H,
4.60; N, 9.21. Found: C, 65.10; H, 4.66; N, 9.25%.